The key will be defining the type of dopamine change that contributes to the disorder. Notably, for the behaviors assessed in the study, animals with normal DAT protein failed to show behavioral ...

Discovery of dopamine receptors in a previously overlooked part of the brain sheds light on the complex circuitry for anxiety and depression Date: May 7, 2025 Source: The Mount Sinai Hospital ...

Receptors that, when activated, can cause nausea or vomiting or both include dopamine type 2, serotonin type 3, histamine type 1, and muscarinic cholinergic type 1 receptors.

Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.

Although the mechanism of action of this atypical antipsychotic is unknown, the therapeutic effect may be due to a combination of central dopamine type 2 (D2) and serotonin type 2 (5HT2a) receptor ...

Intra-Cellular Therapies Inc. has patented compounds acting as serotonin transporter (SERT), 5-HT2A, dopamine D1 and D2 receptor ligands reported to be useful for the treatment of neurological ...

New York, USA, June 03, 2025 (GLOBE NEWSWIRE) -- Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics ...